Anticipated Costs Post-Approval While neither compound has reached market, pricing for similar medications provides context: Semaglutide (Wegovy) Approximately $1,300-$1,500 monthly without insurance Tirzepatide (Zepbound) Approximately $1,000-$1,200 monthly without insurance Cagrilintide and retatrutide would likely fall in similar price ranges, with combination therapy potentially costing $2,000-$3,000 monthly without insurance coverage
The term "GLP-1 patch" reflects marketing terminology and consumer search behavior, not verified biological mechanism
Patients should always follow the specific advice provided by their surgical team and anaesthetist, which will be tailored to their individual circumstances and local NHS Trust protocols, rather than making independent decisions about stopping medications
For one, carnitine reduces oxidative damage in the body's nitric oxide (NO)